China Pharma Holdings Inc. (CPHI)
NYSE · Healthcare
China Pharma Holdings Inc. Shareholder Equity 2010–2025
China Pharma Holdings Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- China Pharma Holdings Inc. shareholder equity as of December 31, 2025: 22.7M, a 193.50% increase year-over-year.
- China Pharma Holdings Inc. shareholder equity for 2025 were 22.7M, a 193.50% increase from 2024.
- China Pharma Holdings Inc. shareholder equity for 2024 were 7.7M, a 3.93% increase from 2023.
- China Pharma Holdings Inc. shareholder equity for 2023 were 7.5M, a 73.77% increase from 2022.
- China Pharma Holdings Inc. shareholder equity for 2022 were 4.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| China Pharma Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $23 |
| 2024 | $8 |
| 2023 | $7 |
| 2022 | $4 |
| 2021 | $6 |
| 2020 | $8 |
| 2019 | $9 |
| 2018 | $30 |
| 2017 | $43 |
| 2016 | $59 |
| 2015 | $73 |
| 2014 | $93 |
| 2013 | $133 |
| 2012 | $149 |
| 2011 | $142 |
China Pharma Holdings Inc. Shareholder Equity — FAQ
China Pharma Holdings Inc. (CPHI) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPHI's shareholder equity history?
The chart and table above show China Pharma Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.